Army Low‑Testosterone Screening Could Flag Up to 25% of Soldiers, Study Warns

A new JAMA study indicates that the Army’s mandatory low‑testosterone screening, announced by Defense Secretary Pete Hegseth in July, could label up to one in four active‑duty members as having low testosterone. The study argues that the true prevalence of the condition is likely far lower, raising concerns that the screening will trigger a chain of unnecessary medical evaluations. Such evaluations risk inaccurate results, inappropriate testing, and overtreatment, potentially causing harm including infertility. The Endocrine Society and the American Urological Association have cautioned against blanket screenings for these reasons. Despite these warnings, the Pentagon released clinical guidance in September and continues to push the program forward.